Cargando…

Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse model

Neurodegenerative disorders, such as Alzheimer’s disease (AD), have the gradual onset of neurobiological changes preceding clinical diagnosis by decades. To elucidate how brain dysfunction proceeds in neurodegenerative disorders, we performed longitudinal characterization of behavioral, morphologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Qing, Kumar, Manasa, Frazier, Allea, Williams, Jamal B., Zhao, Shengkai, Yan, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683589/ https://www.ncbi.nlm.nih.gov/pubmed/37925173 http://dx.doi.org/10.18632/aging.205057

Ejemplares similares

Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model
por: Wang, Wei, et al.
Publicado: (2021)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
por: Williams, Jamal B., et al.
Publicado: (2023)

Longitudinal characterization of retinal vasculature alterations with optical coherence tomography angiography in a mouse model of tauopathy
por: Buscho, Seth, et al.
Publicado: (2022)

Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
por: Samaey, Celine, et al.
Publicado: (2019)

Transmission and spreading of tauopathy in transgenic mouse brain
por: Clavaguera, Florence, et al.
Publicado: (2009)

Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
por: Wang, Xiaohai, et al.
Publicado: (2018)

Neural stem cell transplantation alleviates functional cognitive deficits in a mouse model of tauopathy
por: Zhang, He-Ao, et al.
Publicado: (2021)

Integrated analysis of the aging brain transcriptome and proteome in tauopathy
por: Mangleburg, Carl Grant, et al.
Publicado: (2020)

Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
por: Barini, Erica, et al.
Publicado: (2016)

Primary Feline Tauopathy: Clinical, Morphological, Immunohistochemical, and Genetic Studies
por: Vidal-Palencia, Laura, et al.
Publicado: (2023)

Novel autoimmune response in a tauopathy mouse model
por: Nogueras-Ortiz, Carlos J., et al.
Publicado: (2014)

Using mass spectrometry to validate mouse models of tauopathy
por: Yan, Yan, et al.
Publicado: (2023)

Astrocytes in Tauopathies
por: Reid, Matthew J., et al.
Publicado: (2020)

NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy
por: Rossi, Francesca, et al.
Publicado: (2018)

Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy
por: Williams, Tosha, et al.
Publicado: (2020)

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
por: Chatterjee, Snehajyoti, et al.
Publicado: (2018)

Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
por: Garwood, Claire J., et al.
Publicado: (2010)

Analysis of in vivo turnover of tau in a mouse model of tauopathy
por: Yamada, Kaoru, et al.
Publicado: (2015)

Early alterations of neurovascular unit in the retina in mouse models of tauopathy
por: Xia, Fan, et al.
Publicado: (2021)

Plasticity in visual cortex is disrupted in a mouse model of tauopathy
por: Papanikolaou, Amalia, et al.
Publicado: (2022)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
por: Sahara, Naruhiko, et al.
Publicado: (2023)

Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
por: Schaeffer, Véronique, et al.
Publicado: (2012)

Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
por: Shi, Yang, et al.
Publicado: (2019)

Numb regulates Tau levels and prevents neurodegeneration in tauopathy mouse models
por: Lacomme, Marine, et al.
Publicado: (2022)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
por: Arouche-Delaperche, L., et al.
Publicado: (2023)

Common mouse models of tauopathy reflect early but not late human disease
por: Wenger, Kathrin, et al.
Publicado: (2023)

Heritability in frontotemporal tauopathies
por: Forrest, Shelley L., et al.
Publicado: (2019)

Clinical Spectrum of Tauopathies
por: Olfati, Nahid, et al.
Publicado: (2022)

Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
por: Rickner, Hannah Drew, et al.
Publicado: (2022)

Characterization of (18)F-PM-PBB3 ((18)F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy
por: Weng, Chi-Chang, et al.
Publicado: (2020)

Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
por: Melis, Valeria, et al.
Publicado: (2015)

Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy
por: Matsumoto, Gen, et al.
Publicado: (2018)

Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions
por: Sidoryk-Wegrzynowicz, Marta, et al.
Publicado: (2017)

Impaired speed encoding and grid cell periodicity in a mouse model of tauopathy
por: Ridler, Thomas, et al.
Publicado: (2020)

Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
por: Fairley, Lauren H., et al.
Publicado: (2021)

Seed-competent tau monomer initiates pathology in a tauopathy mouse model
por: Mirbaha, Hilda, et al.
Publicado: (2022)

Positron Emission Tomography in Animal Models of Tauopathies
por: Cao, Lei, et al.
Publicado: (2022)

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
por: López González, Irene, et al.
Publicado: (2016)

Transcriptomic analysis of human brains with Alzheimer’s disease reveals the altered expression of synaptic genes linked to cognitive deficits
por: Williams, Jamal B, et al.
Publicado: (2021)

Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy
por: Choi, Yun-Beom, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lhfl2h7k1jp3ddgj7slao0tth